)
Octapharma is one of the largest human protein manufacturers in the world.
Family-owned since 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products treat hundreds of thousands of patients every year across three therapeutic areas: haematology, immunotherapy and critical care.
We develop and produce medicines based on proteins derived from human cell lines and human plasma.
:quality(80))
+
employees
state-of-the-art manufacturing sites
preclinical and clinical R&D sites
+
plasma donation centres
€ bn
revenue in 2025
)
Our Annual Report provides a comprehensive overview of who we are and what we do.
Continue to ensure the safe and optimal use of human proteins and expand the portfolio to deliver innovative health solutions advancing human life.
Prioritise IG yield improvements and optimise plasma collection / production capacities to support future growth and increase revenues per litre.
Strengthen our commitment to haematology, immunology and critical care by enhancing and expanding our portfolio into adjacent areas and new indications.
Expand accessibility of our therapies to more patients around the world.
Reaffirm Octapharma’s family ownership, long-term vision and commitment to patients and responsible value creation.
Remain an employer of choice.
